Seven Eight Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-35,478
| Closed | -$1.97M | – | 497 |
|
|
2024
Q3 | $1.97M | Buy |
35,478
+23,718
| +202% | +$1.32M | 0.18% | 186 |
|
|
2024
Q2 | $483K | Sell |
11,760
-35,796
| -75% | -$1.47M | 0.05% | 525 |
|
|
2024
Q1 | $2.22M | Buy |
47,556
+1,650
| +4% | +$77K | 0.23% | 128 |
|
|
2023
Q4 | $2.2M | Buy |
45,906
+26,831
| +141% | +$1.28M | 0.25% | 108 |
|
|
2023
Q3 | $680K | Buy |
19,075
+5,271
| +38% | +$188K | 0.08% | 330 |
|
|
2023
Q2 | $637K | Buy |
+13,804
| New | +$637K | 0.11% | 260 |
|
|
2022
Q4 | – | Sell |
-12,852
| Closed | -$532K | – | 590 |
|
|
2022
Q3 | $532K | Buy |
+12,852
| New | +$532K | 0.11% | 263 |
|
|
2022
Q2 | – | Sell |
-3,489
| Closed | -$253K | – | 580 |
|
|
2022
Q1 | $253K | Buy |
+3,489
| New | +$253K | 0.03% | 449 |
|
|
2021
Q3 | – | Sell |
-8,651
| Closed | -$825K | – | 698 |
|
|
2021
Q2 | $825K | Buy |
+8,651
| New | +$825K | 0.12% | 307 |
|
|
2020
Q1 | – | Sell |
-14,748
| Closed | -$630K | – | 658 |
|
|
2019
Q4 | $630K | Sell |
14,748
-26,800
| -65% | -$1.14M | 0.03% | 510 |
|
|
2019
Q3 | $1.78M | Buy |
+41,548
| New | +$1.78M | 0.09% | 321 |
|
|
2016
Q1 | – | Sell |
-300
| Closed | -$34K | – | 662 |
|
|
2015
Q4 | $34K | Buy |
+300
| New | +$34K | 0.02% | 462 |
|
|
2014
Q4 | – | Sell |
-100
| Closed | -$5.66K | – | 617 |
|
|
2014
Q3 | $5.66K | Buy |
+100
| New | +$5.66K | ﹤0.01% | 480 |
|